Literature DB >> 21910806

Endocytosis of the neuronal glycine transporter GLYT2: role of membrane rafts and protein kinase C-dependent ubiquitination.

Jaime de Juan-Sanz1, Francisco Zafra, Beatriz López-Corcuera, Carmen Aragón.   

Abstract

Glycinergic neurotransmission is terminated by sodium- and chloride-dependent plasma membrane transporters. The neuronal glycine transporter 2 (GLYT2) supplies the terminal with substrate to refill synaptic vesicles containing glycine. This crucial process is defective in human hyperekplexia, a condition that can be caused by mutations in GLYT2. Inhibitory glycinergic neurotransmission is modulated by the GLYT2 exocytosis/endocytosis equilibrium, although the mechanisms underlying the turnover of this transporter remain elusive. We studied GLYT2 internalization pathways and the role of ubiquitination and membrane raft association of the transporter in its endocytosis. Using pharmacological tools, dominant-negative mutants and small-interfering RNAs, we show that the clathrin-mediated pathway is the primary mechanism for constitutive and regulated GLYT2 endocytosis in heterologous cells and neurons. We show that GLYT2 is constitutively internalized from cell surface lipid rafts, remaining associated with rafts in subcellular recycling structures. Protein kinase C (PKC) negatively modulates GLYT2 via rapid and dynamic redistribution of GLYT2 from raft to non-raft membrane subdomains and increasing ubiquitinated GLYT2 endocytosis. This biphasic mechanism is a versatile means to modulate GLYT2 behavior and hence, inhibitory glycinergic neurotransmission. These findings may reveal new therapeutic targets to address glycinergic pathologies associated with alterations in GLYT2 trafficking.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21910806     DOI: 10.1111/j.1600-0854.2011.01278.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  19 in total

1.  Flotillins regulate membrane mobility of the dopamine transporter but are not required for its protein kinase C dependent endocytosis.

Authors:  Tatiana Sorkina; John Caltagarone; Alexander Sorkin
Journal:  Traffic       Date:  2013-03-11       Impact factor: 6.215

Review 2.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

3.  A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2.

Authors:  Cecilio Giménez; Gonzalo Pérez-Siles; Jaime Martínez-Villarreal; Esther Arribas-González; Esperanza Jiménez; Enrique Núñez; Jaime de Juan-Sanz; Enrique Fernández-Sánchez; Noemí García-Tardón; Ignacio Ibáñez; Valeria Romanelli; Julián Nevado; Victoria M James; Maya Topf; Seo-Kyung Chung; Rhys H Thomas; Lourdes R Desviat; Carmen Aragón; Francisco Zafra; Mark I Rees; Pablo Lapunzina; Robert J Harvey; Beatriz López-Corcuera
Journal:  J Biol Chem       Date:  2012-06-29       Impact factor: 5.157

4.  Molecular basis of the dominant negative effect of a glycine transporter 2 mutation associated with hyperekplexia.

Authors:  Esther Arribas-González; Jaime de Juan-Sanz; Carmen Aragón; Beatriz López-Corcuera
Journal:  J Biol Chem       Date:  2014-12-05       Impact factor: 5.157

5.  Presynaptic control of glycine transporter 2 (GlyT2) by physical and functional association with plasma membrane Ca2+-ATPase (PMCA) and Na+-Ca2+ exchanger (NCX).

Authors:  Jaime de Juan-Sanz; Enrique Núñez; Francisco Zafra; María Berrocal; Isaac Corbacho; Ignacio Ibáñez; Esther Arribas-González; Daniel Marcos; Beatriz López-Corcuera; Ana M Mata; Carmen Aragón
Journal:  J Biol Chem       Date:  2014-10-14       Impact factor: 5.157

6.  Forskolin stimulation promotes urea transporter UT-A1 ubiquitination, endocytosis, and degradation in MDCK cells.

Authors:  Hua Su; Conner B Carter; Oskar Laur; Jeff M Sands; Guangping Chen
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-22

Review 7.  Post-translational modifications of transporters.

Authors:  Lindsay C Czuba; Kathleen M Hillgren; Peter W Swaan
Journal:  Pharmacol Ther       Date:  2018-06-30       Impact factor: 12.310

8.  Binding to syntenin-1 protein defines a new mode of ubiquitin-based interactions regulated by phosphorylation.

Authors:  Sundaresan Rajesh; Ružica Bago; Elena Odintsova; Gayrat Muratov; Gouri Baldwin; Pooja Sridhar; Sandya Rajesh; Michael Overduin; Fedor Berditchevski
Journal:  J Biol Chem       Date:  2011-09-26       Impact factor: 5.157

9.  Calnexin-assisted biogenesis of the neuronal glycine transporter 2 (GlyT2).

Authors:  Esther Arribas-González; Pablo Alonso-Torres; Carmen Aragón; Beatriz López-Corcuera
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

Review 10.  Targeting tumor invasion: the roles of MDA-9/Syntenin.

Authors:  Timothy P Kegelman; Swadesh K Das; Luni Emdad; Bin Hu; Mitchell E Menezes; Praveen Bhoopathi; Xiang-Yang Wang; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Expert Opin Ther Targets       Date:  2014-09-15       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.